3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
10
Leukemia, Myeloid, Acute
9
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Multiple Myeloma
5
Lymphoma, Large B-Cell, Diffuse
5
Small Cell Lung Carcinoma
4
Sarcoma
4
Recurrence
4
Neuroblastoma
4
Central Nervous System Neoplasms
4
Lymphoma, T-Cell
3
Lymphoma, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Burkitt Lymphoma
3
Teratoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Optic Nerve Glioma
2
Oligodendroglioma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Congenital Abnormalities
2
Breast Neoplasms
2
Interventions
Paclitaxel
57
Carboplatin
51
Bevacizumab
41
Taxes
28
liposomal doxorubicin
21
Gemcitabine
19
Immunoglobulin G
17
Disulfides
17
pembrolizumab
15
Topotecan
12
rucaparib
10
Cyclophosphamide
9
Cisplatin
9
Docetaxel
8
olaparib
7
Doxorubicin
7
pazopanib
6
mirvetuximab soravtansine
6
cediranib
6
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
sargramostim
4
niraparib
4
Surgical Procedures, Operative
4
Drug Therapy
4
Cytoreduction Surgical Procedures
4
Albumin-Bound Paclitaxel
4
veliparib
3
fludarabine phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Fallopian Tube Neoplasms
×
etoposide phosphate
×
Clear all
No trials found.